Form 4: Century Therapeutics' Chief Operations Officer Sells Shares to Cover Tax Obligations

Adrienne Farid, Chief Operations Officer of Century Therapeutics, sold 913 shares of common stock on May 3, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On May 3, 2024, Adrienne Farid, the Chief Operations Officer of Century Therapeutics, Inc. (IPSC), sold 913 shares of common stock.
• The sale was executed at a price of $3.106 per share.
• The transaction was conducted to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following the transaction, Farid directly owns 137,236 shares of Century Therapeutics.
• The sale was automatic and not at the discretion of the Reporting Person.

Sentiment

Score: 5

Explanation: Neutral sentiment as the transaction is related to tax obligations and doesn't necessarily indicate a positive or negative outlook on the company.

Future Outlook

There is no future outlook provided in this document.

Industry Context

Form 4 filings are routine disclosures required by the SEC when company insiders, like officers and directors, trade their company's stock. These filings provide transparency into insider transactions, allowing investors to see if those with inside knowledge of the company are buying or selling shares. It is important to note that this sale was to cover tax obligations and may not reflect the officer's sentiment on the company's future prospects.

Stakeholder Impact

• The sale of shares by a company officer could be perceived negatively by some shareholders, but the explanation provided mitigates this concern.

Key Dates